459810-97-0

Basic information

• Product Name: 5-FORMYL-2-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID
• Synonyms: 5-FORMYL-2-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID;3-Borono-4-(trifluoromethoxy)benzaldehyde
• CAS NO: 459810-97-0
• Molecular Formula: C₈H₆BF₃O₄
• Molecular Weight: 233.9370496
• Mol File: 459810-97-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-FORMYL-2-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-FORMYL-2-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID(459810-97-0)
• EPA Substance Registry System: 5-FORMYL-2-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID(459810-97-0)

Safety Data

• Hazardous Substances Data: 459810-97-0(Hazardous Substances Data)

Downstream Products

• 532440-82-7 3-(1-Benzyl-3,3,5-trimethyl-2-oxo-2,3-dihydro-1H-indol-6-yl)-4-trifluoromethoxy-benzaldehyde 
• 932400-79-8 3-(5-ethyl-4-oxo-2,3,4,5-tetrahydro-1H-cyclopenta[c]quinolin-8-yl)-4-trifluoromethoxybenzaldehyde 
• 932368-08-6 7-(5-Formyl-2-trifluoromethoxy-phenyl)-4,4,6-trimethyl-2-oxo-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester 
• 500165-24-2 3-(1,4,4,6-tetramethyl-2-oxo-1,2,3,4-tetrahydro-quinolin-7-yl)-4-trifluoromethoxy-benzaldehyde 
• 459811-04-2 3-(1-ethyl-4,4,6-trimethyl-2-oxo-1,2,3,4-tetrahydro-quinolin-7-yl)-4-trifluoromethoxy-benzaldehyde 
• 945042-02-4 C₂₃H₂₄NO₃F₃ 
• 945042-03-5 C₂₃H₂₄NO₃F₃ 
• 932384-62-8 3-(1-ethyl-4,4,6-trimethyl-2-oxo-1,4-dihydro-2H-benzo[d][1,3]oxazin-7-yl)-4-trifluoromethoxy-benzaldehyde 
• 932384-38-8 3-(4-Ethyl-2,2,7-trimethyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4-trifluoromethoxy-benzaldehyde 
• 932384-56-0 6-(5-Acetyl-2-trifluoromethoxy-phenyl)-4-ethyl-2,2,7-trimethyl-4H-benzo[1,4]oxazin-3-one 

Relevant articles and documents

N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases

The present invention relates to certain compounds of Formula (I) which can be useful in the treatment of diseases, such as, cancer, metabolic disorders, Type 2 Diabetes, dyslipidemia and/or hyperchloesterolemia:

RXR activating molecules

Disclosed are molecules that activate an RXR receptor, wherein the molecule comprises an RXR binding portion which binds the RXR receptor and comprises a side pocket contacting residue which contacts a side-pocket 1 of an RXR receptor.